CRISPR / Gene Editing News Content Archive

23 posts · Page 1 of 1

1. Gene Editing Weekly — May 10–17, 20262026-05-17
2. Gene Editing Weekly — May 17–22, 20262026-05-22
3. Gene Editing Weekly — May 22–29, 20262026-05-29
4. Gene Editing Weekly — May 29–June 5, 20262026-06-05
5. Gene Editing Weekly — June 5–12, 20262026-06-12
6. Gene Editing Weekly — June 12–19, 20262026-06-19
7. Gene Editing Weekly — June 19–26, 20262026-06-26
8. Gene Editing Weekly - Jun 26-Jul 32026-07-03
9. Gene Editing Weekly - July 10-17, 2026: ex vivo consistency, precision platforms, and bespoke trials2026-07-17
10. Gene Editing Weekly — July 17-24, 2026: a new clinical entry point, large-DNA insertion, and a governance failure2026-07-24
11. Gene Editing Weekly — July 24–31, 2026: DMD base-editing follow-up, split editors, and personalized therapies2026-07-31
12. Gene Editing Weekly — August 7–14, 2026: a clinical edge case, safer editing tools, and Sangamo's asset sale2026-08-14
13. Gene Editing Weekly — August 14–21, 2026: FDA's CGT guidance, Genglycos, and the editing quality-control stack2026-08-21
14. Gene Editing Weekly — August 22–28, 2026: PBGENE-DMD enters the clinic as prime assembly stretches the payload envelope2026-08-28
15. Gene editing weekly — August 29–September 4, 2026: One-year editing, $400 million runway, and the cost of delivery2026-09-04
16. Gene Editing Weekly — September 5–11, 2026: Intellia enters priority review as multi-ethnic base editing reports 12-month durability2026-09-11
17. Gene Editing Weekly — September 12–18, 2026: a first-in-disease gene therapy, a rolling IND pilot, and Cellectis's in vivo pivot2026-09-18
18. Gene Editing Weekly — September 19–25, 2026: an AI find re-rates the sector, a prime-editing IND, and an epigenetic silencer for hepatitis B2026-09-25
19. Gene Editing Weekly — September 26–October 2, 2026: a base-editing trade-secrets suit, Germany's first Casgevy treatment, and a second route to fetal hemoglobin2026-10-02
20. Gene Editing Weekly — October 3–9, 2026: an in vivo prime editor reaches a patient, Editas clears its first human trial, and Caribou gives up on off-the-shelf CAR-T2026-10-09
21. Gene Editing Weekly — October 10–16, 2026: a base editor restores glucose production in GSDIa patients, and a census finds two individualized editing trials2026-10-16
22. Gene Editing Weekly — October 17–23, 2026: a retrotransposon builds a CAR-T inside a mouse, and China's pathway counts 112 filed projects2026-10-23
23. Gene Editing Weekly — October 24–30, 2026: HG302 edits DMD in four boys and kills one at the high dose, and the FDA drafts a one-patient approval path2026-10-30

Explore more channels on Discover